跳转到内容

勃来诺

维基百科,自由的百科全书
勃来诺
臨床資料
其他名稱Ethylnorandrostenol; 17α-Ethyl-19-norandrost-5-en-17β-ol
给药途径口服给药
识别信息
  • (8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,4,7,8,9,10,11,12,14,15, 16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
    OR
    (1S,2R,10R,11S,14S,15S)-14-ethyl-15-methyltetracyclo[8.7.0.02,7.011,15]heptadec-7-en-14-ol
CAS号16915-78-9  checkY
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.037.226 編輯維基數據鏈接
化学信息
化学式C20H32O
摩尔质量288.47 g/mol
3D模型(JSmol英语JSmol
  • CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@H]3CCCC4)C)O
  • InChI=1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h8,15-18,21H,3-7,9-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1 ☒N
  • Key:VGXLQFPZGUQVQW-XGXHKTLJSA-N ☒N

勃来诺(英語:BolenolINNUSAN,也被称为17α-乙基-19-去甲雄甾-5-烯-17β-醇,17α-ethyl-19-norandrost-5-en-17β-ol,乙雌异烯醇,ethylnorandrostenol)是一种同化類固醇(AAS)药物,其碳骨架结构可以看做是雌烷的17α-乙基衍生物19-去甲孕烷的17α别构物[1],在1969年开始有文献报道,但从未上市过[1]

另见

[编辑]

参考文献

[编辑]



pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy